| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3341981 | Autoimmunity Reviews | 2011 | 6 Pages |
Abstract
⺠IVIg has become a relevant treatment option in various immune-mediated diseases, including PM and DM. ⺠SCIg could act at different levels than IVIg in modulating the pathogenic immune response. ⺠The use of SCIg reduces the risk of adverse effects and the cost of IVIg treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Maria Giovanna Danieli, Lucia Pettinari, Romina Moretti, Francesco Logullo, Armando Gabrielli,